Blog

Multi-Frequency Bioimpedance From Aminogram: A Key Tool for Public Health

Introduction Multi-frequency bioimpedance has emerged as a revolutionary technology in the field of public health, offering a precise and non-invasive evaluation of body composition. Aminogram, a leading company in the development of multi-frequency bioimpedance devices, has designed tools that not only improve prevention and diagnosis but also optimize the monitoring...

GLP-1 Agonists in the Treatment of Obesity: Benefits, Risks, and the Role of Bioimpedance

Gildardo Uribe GilND- MgSC, Phd (c) en SP Obesity is a complex condition that affects millions of people worldwide, with WHO projections indicating that approximately 4 billion adults will be living with overweight or obesity by 2030. In addition to metabolic and cardiovascular impacts, excess body fat is associated with...

Obesity and Physical Activity: Benefits and Management Modalities

Learn how physical activity, combining aerobic and resistance exercises, improves body composition and supports effective obesity management.

Obesity and Sarcopenia: The Importance of Muscle Mass in Management

According to a recent expert consensus¹, obesity is defined as a condition characterized by a body mass index (BMI) greater than 30 kg/m², combined with excess fat mass that leads to clinical complications impairing the patient’s health. From a pathophysiological perspective, this excess fat mass causes low-grade systemic inflammation...

New Approach to Obesity: BIA as the Key to Diagnosis and Monitoring

Introduction to the new approach to obesity: Results of an expert commission On January 14, 2025, the results of a commission composed of medical specialists and researchers were published in The Lancet Diabetology & Endocrinology. Their goal was to rethink the framework for understanding and managing obesity¹. Globally, the World...

Capacitance: A Promising New Tool to Detect and Monitor Insulin Resistance and Type 2 Diabetes?

In France, in 2020, it was estimated that 5.3% of the French population, or 3.5 million people, were being treated for diabetes, of which 90% had type 2 diabetes — a figure that has been steadily increasing since 2012. Diabetes is characterized by a disruption in glucose metabolism and...